Tenon Medical, Inc. (TNONW) company profile

Tenon Medical, Inc. is a medical device company that develops surgical solutions for sacro-pelvic disorders, particularly conditions affecting the sacroiliac joint that cause lower back pain. Its primary product offerings include The Catamaran SI Joint Fusion System, which utilizes a single titanium implant through a less invasive approach, and The SImmetry + SI Joint Fusion System, a minimally invasive lateral access system designed to achieve biological fusion across the joint. The company's solutions target clinical procedures including primary sacroiliac joint fusions, revisions of failed implants, and fusions performed adjacent to spine fusion constructs. The company serves healthcare providers, including surgeons, clinicians, and hospitals treating adult sacroiliac joint pathology.

Operations are centered in the United States, which serves as the primary commercial focus for its surgical systems. Tenon Medical maintains its principal executive offices and headquarters in Los Gatos, California, after relocating from San Ramon, California.

Summary of the business section of Tenon Medical's latest annual report, written by StockData.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“Per Share Total Initial public offering price $ 5.00 $ 16,000,000 Underwriting discounts and commissions (1) $ 0.35 $ 1,120,000 Proceeds, before expenses, to us $ 4.65 $ 14,880,000 (1) Does not include a non-accountable expense allowance equal to 1% of the gross proceeds of this offering, payable to The Benchmark C”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

“of March 27, 2026, we have a total of 26 employees, all of whom are full-time, and nine senior consulting advisors of various specialty”